TapImmune Inc. (OTCMKTS:TPIV) Spikes Once More

Last Friday saw TapImmune Inc. (OTCMKTS:TPIV) rise 9.80% up the charts, in spite of the apparent lack of developments around the company lately.

TPIV hasn’t had any new press releases since the announcement of the appointment of John N. Bonfiglio, to its Board of Directors – and, as the charts indicate, that news failed to make a splash. No, the ticker was jerked into motion almost a week later. So why would that be?

Truth be told, there is no way to be certain. It appears that many of the regular commenters on the company’s message boards believe that TPIV stock is currently severely oversold, and is poised for a huge bounce. This is probably why the general opinion seems to be that that TPIV‘s breakout is inevitable and, indeed – imminent.

Some TPIV enthusiasts claim that Friday’s climb, as well as the one they expect on Monday and beyond, is because the “stock was alerted on 6 private newsletters”. There seem to be no evidence that this is the case, but if the touts are really private, that is sort of the point. If that is the case, only time will reveal the truth.

Whatever the rise’s cause may be, long term investors and opportunistic traders alike should be very wary at this point. With no news or filings for about 10 days now, TPIV finds itself in an elevated, but vulnerable position, from which it may fall at any time for almost any reason – or even for no reason whatsoever. Indeed, we’ve seen TPIV plummet in spite of good news on multiple occasions in the past.

Which is why due caution is advised when dealing with this stock.